TheraRadar
← Back
Data updated: Mar 29, 2026

RHODES PHARMS

ImmunologyInfectious DiseaseMetabolic
Generics

RHODES PHARMS is a generic drug manufacturer focused on Immunology, Infectious Disease, Metabolic. Key products include APTENSIO XR.

1988
Since
23
Drugs
-
Trials
670
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 20%
1 drugs
Infectious Disease 20%
1 drugs
Metabolic 20%
1 drugs
Cardiovascular 20%
1 drugs
Respiratory 20%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...